KRISTEN MORROW: Open Payments
NPI 1245670801 · VERMILLION, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$820 in 57 payments from 15 companies in 2025. Trend: 2023 $290 · 2024 $681 · 2025 $820
Food & beverage: $820
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $169 |
| ABBVIE INC. | 15 | $144 |
| Vanda Pharmaceuticals Inc. | 5 | $101 |
| Otsuka America Pharmaceutical, Inc. | 5 | $90 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| PFIZER INC. | 3 | $47 |
| Alkermes, Inc. | 2 | $36 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| E.R. Squibb & Sons, L.L.C. | 2 | $29 |
| Amgen Inc. | 1 | $20 |
Products named: CAPLYTA, VRAYLAR, FANAPT, REXULTI, Auvelity, ELIQUIS, ARISTADA, Jornay PM.
Industry payments across SD — which companies pay providers there.
